CID 46200989

Mk-7725

Structural Information

Molecular Formula
C25H19F6N5O5S
SMILES
CC(C)(C1=NC(=NO1)C2=C3C(=CC=C2)NC4=C(CN3S(=O)(=O)C5=CC=C(C=C5)OC(F)(F)F)C=CC(=N4)C(F)(F)F)O
InChI
InChI=1S/C25H19F6N5O5S/c1-23(2,37)22-34-21(35-41-22)16-4-3-5-17-19(16)36(12-13-6-11-18(24(26,27)28)33-20(13)32-17)42(38,39)15-9-7-14(8-10-15)40-25(29,30)31/h3-11,37H,12H2,1-2H3,(H,32,33)
InChIKey
WQQNCCUPGPFWOI-UHFFFAOYSA-N
Compound name
2-[3-[6-[4-(trifluoromethoxy)phenyl]sulfonyl-2-(trifluoromethyl)-5,11-dihydropyrido[3,2-c][1,5]benzodiazepin-7-yl]-1,2,4-oxadiazol-5-yl]propan-2-ol
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

4
References

4
Patents

615.10114 Da
Monoisotopic Mass

4.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 616.10842 214.6
[M+Na]+ 638.09036 217.6
[M+NH4]+ 633.13496 212.9
[M+K]+ 654.06430 217.2
[M-H]- 614.09386 208.8
[M+Na-2H]- 636.07581 214.1
[M]+ 615.10059 213.2
[M]- 615.10169 213.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe